Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pak C Ng

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Neonatology|June 25, 2011
Erythromycin as a prokinetic agent in newborns--useful or doubtful. Commentary on Y. Mansi et al.: Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants (Neonatology 2011;100:290-294)Pak C Ng
Current Opinion in Pediatrics|March 18, 2011
Editorial comment: neonatology and perinatologyPak C Ng
Pediatrics|October 3, 2008
Is there a "normal" range of serum cortisol concentration for preterm infants?Pak C Ng
Neonatology|February 17, 2009
Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infantsPak C Ng
Neonatology|July 5, 2012
Biomarkers in neonatology: the next generation of testsPak C Ng, Hugh S Lam
Clinics in Perinatology|September 4, 2010
Biomarkers for late-onset neonatal sepsis: cytokines and beyondPak C Ng, Hugh S Lam
Pathology|January 19, 2008
Biochemical markers of neonatal sepsisHugh S Lam, Pak C Ng
Biomarkers in Medicine|May 19, 2010
Biomarkers in neonatal infectionHugh S Lam, Pak C Ng
Current Opinion in Pediatrics|December 24, 2010
Use of prokinetics in the preterm infantHugh S Lam, Pak C Ng
Current Opinion in Pediatrics|April 8, 2006
Diagnostic markers for neonatal sepsisPak C Ng, Hugh S Lam
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Neonatology|June 25, 2011
Erythromycin as a prokinetic agent in newborns--useful or doubtful. Commentary on Y. Mansi et al.: Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants (Neonatology 2011;100:290-294)Pak C Ng
Current Opinion in Pediatrics|March 18, 2011
Editorial comment: neonatology and perinatologyPak C Ng
Pediatrics|October 3, 2008
Is there a "normal" range of serum cortisol concentration for preterm infants?Pak C Ng
Neonatology|February 17, 2009
Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infantsPak C Ng
Neonatology|July 5, 2012
Biomarkers in neonatology: the next generation of testsPak C Ng, Hugh S Lam
Clinics in Perinatology|September 4, 2010
Biomarkers for late-onset neonatal sepsis: cytokines and beyondPak C Ng, Hugh S Lam
Pathology|January 19, 2008
Biochemical markers of neonatal sepsisHugh S Lam, Pak C Ng
Biomarkers in Medicine|May 19, 2010
Biomarkers in neonatal infectionHugh S Lam, Pak C Ng
Current Opinion in Pediatrics|December 24, 2010
Use of prokinetics in the preterm infantHugh S Lam, Pak C Ng
Current Opinion in Pediatrics|April 8, 2006
Diagnostic markers for neonatal sepsisPak C Ng, Hugh S Lam
Pageof 6